J Adolesc Young Adult Oncol
Hispanic or LatinoSocial ClassSurvivors
Dr. Alison Semrad, DO
NPI1003892993
- Medicare services, 2019
- 58
- Part D claims, 2024
- 1,294
- Publications
- 14
- Clinical trials
- 10
- MIPS score, 2024
- 75
- Practice address
- 10121 Pine Ave, Truckee, CA 96161
- Practice phone
- Call (530) 587-6011
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Semrad's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Alison Semrad is an endocrinologist in Truckee, California
Dr. Semrad practices at Tahoe Forest Hospital in Truckee, California, part of Tahoe Forest Hospital District.
Dr. Semrad's NPI, 1003892993, was assigned on December 21, 2005. Dr. Semrad graduated from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 2004. Dr. Semrad's California license number on file is 20A9354.
NPI and contact details
- NPI
- 1003892993NPI Registry (opens in a new tab)
- NPI enumeration date
- December 21, 2005
- NPI status
- Active
- Practice phone
- (530) 587-6011
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 48
- Medical school graduation
- 2004
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Alison Semrad practices at Tahoe Forest Hospital in Truckee, California
Dr. Semrad's primary practice is Tahoe Forest Hospital, at 10121 Pine Ave, Truckee, CA 96161 in Nevada County. The practice phone is (530) 587-6011.
- Tahoe Forest Hospital10121 Pine Ave, Truckee, CA 96161 · Nevada CountyPhone(530) 587-6011
Source: Dmand AI Affiliation Data
Dr. Alison Semrad is affiliated with 2 sites of care and 2 medical groups
Dr. Semrad's primary practice is Tahoe Forest Hospital in Truckee, California, part of Tahoe Forest Hospital District. The medical group on file is Tahoe Forest MultiSpecialty Clinics. Dmand AI also links Dr. Semrad to 1 more group practice or clinic and 1 medical group, each named with a free account.
Tahoe Forest MultiSpecialty Clinics1 group practice or clinicName with a free account1 medical groupName with a free account
See all 4 affiliations for Dr. SemradSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Alison Semrad's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Semrad practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Tahoe Forest Hospital | Available with a free account |
| +1 more site and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Semrad practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Tahoe Forest Hospital District and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Alison Semrad is one of 1,062 endocrinologists in California
Endocrinology, diabetes and metabolism is Dr. Semrad's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Semrad is board certified in endocrine certification in neck ultrasound by the ACE. Dr. Semrad has a license on file in California.
Specialties and state licenses
- Endocrinology, diabetes and metabolism, CaliforniaPrimary
Endocrinologists near Dr. Semrad
Counts of endocrinologists with a Dmand AI profile, by place and practice. Each opens the list.
1,062endocrinologists in California
2endocrinologists in Truckee
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Alison Semrad billed Medicare for 58 services in 2019
CMS data shows 58 Medicare services from Dr. Semrad across 2 procedure codes in 2019, all of them office visits. Medicare paid $2,289 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 201958
Paid by Medicare$2,289
Procedure codes2
Dr. Semrad's Medicare services by type, 2018 to 2019
- 2018
- 2019
- Office and hospital visits
- 2018: 2952019: 5880%
- Imaging
- 2018: 112019: 0100%
- Surgery
- 2018: 152019: 0100%
Dr. Semrad compared with the California median for endocrinologists, 2019
- Dr. Semrad
- California median
- Medicare services
- 58vs 67591% below
- Part D claims
- 1,004vs 1,1049% below
Medians across 994 endocrinologists in California with Dmand AI profiles that report each measure.
Dr. Semrad's most billed Medicare procedure codes, 2019
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Semrad?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Semrad and other endocrinologists in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Alison Semrad's patients have a median age of 72
Across all payers, Dmand AI patient panel data puts Dr. Semrad's median patient age at 72, with 64% women.
Dr. Semrad's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women64%
- Men36%
Source: Dmand AI Patient Panel Data
Dr. Alison Semrad wrote 1,294 Medicare Part D claims in 2024
In 2024, Dr. Semrad wrote 1,294 Medicare Part D claims for 163 patients. 48% of them were for generic drugs. CMS names the drug for 1,004 of them, across 34 drugs with 11 or more claims each, at $396,633 in total drug cost. In 2023, CMS named 782 claims across 25 drugs.
Part D claims, 20241,294
Drugs named by CMS34
Total drug cost$396,633
Part D patients163
Dr. Semrad's Part D claims by kind of drug, 2024
- Generic622 claims48%
- Brand-name570 claims44%
- Other102 claims8%
Dr. Semrad's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 7822024: 1,00428%
Drugs named by CMS: 34 in 2024, 25 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Alison Semrad scored 75 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Semrad for performance year 2024, reported as part of a group.
Dr. Semrad's MIPS scores, performance year 2024
- 75of 100Final score
- 84of 100Quality
- 88of 100Promoting Interoperability
- 40of 100Improvement Activities
- 43of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find endocrinologists like Dr. Semrad by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Alison Semrad has 14 publications on record
Dmand AI links 14 papers to Dr. Semrad, published from 2013 to 2021. 2021 was the busiest year, with 3. The most frequent topics are Thyroid Neoplasms, Adenocarcinoma, Follicular and Thyroidectomy. Dr. Semrad has published most often in Thyroid. Dr. Semrad's most frequent co-authors are Thomas J. Semrad, MAS, MD, Donald Gregory Farwell, MD and Michael J. Campbell, MD.
Papers14
Years published2013 to 2021
Dr. Semrad's papers by year, 2013 to 2021
Topics Dr. Semrad writes about most
- Thyroid Neoplasms
- Adenocarcinoma, Follicular
- Thyroidectomy
Dr. Semrad's most frequent co-authors
- Thomas J. Semrad, MAS, MD7 shared papers
- Donald Gregory Farwell, MD3 shared papers
- Michael J. Campbell, MD2 shared papers
Recent publications by Dr. Semrad
Adenocarcinoma, FollicularReoperationThyroid Cancer, Papillary
Antimicrob Agents Chemother
11-beta-Hydroxysteroid DehydrogenasesAntifungal AgentsCortisone
See who Dr. Semrad researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Semrad works with, so you can find a warm path to the right endocrinologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Alison Semrad has worked on 10 clinical trials
Dmand AI links Dr. Semrad to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.
Clinical trials with Dr. Semrad by phase
- NonePhase 1: no trials
- 4Phase 2: 4 trials
- 1Phase 2/3: 1 trial
- NonePhase 3: no trials
- NonePhase 4: no trials
Trials with no phase (devices, behavioral studies) are left out.
Conditions in Dr. Semrad's trials
- Adenocarcinoma of Lung
- Biliary Atresia
- Low Back Pain
- Malocclusion
- Muscular Atrophy
Investigators on the most trials with Dr. Semrad
- Kader Tawfiq Abdelerahman, MD10 shared trials
- Randa Abdelmasih, MD10 shared trials
- Marjorie E. Affel, MD10 shared trials
Recent clinical trials with Dr. Semrad
Soft Tissue InjuriesWounds and InjuriesA percussion massage gunSpecially designed stainless-steel instruments
Adenocarcinoma of LungAdenocarcinoma
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Alison Semrad received $739 in industry payments from 2017 to 2025
CMS Open Payments shows 10 general payments to Dr. Semrad from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Foundation Medicine, Inc. paid the most, $139.
General payments to Dr. Semrad by program year, 2017 to 2025
Companies that paid Dr. Semrad the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Alison Semrad has 1 award and honors on record
Dmand AI lists 1 award for Dr. Semrad, most recently CMS Stage 1 EHR in 2012.
Awards and honors for Dr. Semrad
- 2012
- CMS Stage 1 EHR
Source: Dmand AI Professional Profile Data
Dr. Alison Semrad graduated from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine
Dr. Semrad graduated from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 2004. Dr. Semrad is a member of AACE, AOA, ATA and ENDO.
- Medical school
- Board certified in endocrine certification in neck ultrasound
- Board certified in endocrinology, diabetes and metabolism
Source: Dmand AI Professional Profile Data
Sources for Dr. Alison Semrad's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Alison Semrad
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Alison Semrad's NPI number?
Dr. Alison Semrad's NPI number is 1003892993. It was assigned on December 21, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Alison Semrad?
Dr. Alison Semrad is an endocrinologist in Truckee, California. The primary specialty in the NPI Registry is Endocrinology, Diabetes & Metabolism Physician (taxonomy code 207RE0101X).
Where does Dr. Alison Semrad practice?
Dr. Semrad practices at 10121 Pine Ave, Truckee, CA 96161. Dr. Semrad's primary practice is Tahoe Forest Hospital in Truckee, California, part of Tahoe Forest Hospital District. Dmand AI also links Dr. Semrad to 1 group practice or clinic and 1 medical group.
What is Dr. Alison Semrad's office phone number?
The practice phone on file for Dr. Semrad is (530) 587-6011.
What is Dr. Alison Semrad's medical license number?
Dr. Semrad's California license number on file is 20A9354.
Which hospitals is Dr. Alison Semrad affiliated with?
Dr. Semrad practices at Tahoe Forest Hospital in Truckee, California.
What medical group is Dr. Alison Semrad part of?
Dr. Semrad is linked to Tahoe Forest MultiSpecialty Clinics. Dmand AI links Dr. Semrad to 1 more medical group.
Does Dr. Alison Semrad accept Medicare?
Yes. CMS data shows Dr. Semrad billed Medicare for 58 services in 2019.
What is Dr. Alison Semrad's MIPS score?
Dr. Semrad's MIPS final score for performance year 2024 is 75 out of 100, reported as part of a group.
Is Dr. Alison Semrad board certified?
Yes. Dr. Semrad is board certified in endocrine certification in neck ultrasound by the ACE.
Show 7 more questionsShow fewer questions
What services does Dr. Alison Semrad bill to Medicare?
In 2019, Dr. Semrad's most billed Medicare services were office visit, established patient (99215) and office visit, established patient (99214).
Where did Dr. Alison Semrad go to medical school?
Dr. Semrad graduated from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 2004.
What drugs does Dr. Alison Semrad prescribe most?
In 2024 Medicare Part D data, Dr. Semrad's most prescribed drugs by claims were Levothyroxine Sodium, Synthroid and Ozempic.
Has Dr. Alison Semrad received payments from drug or device companies?
CMS Open Payments shows $739 in general payments to Dr. Semrad from 8 companies from 2017 to 2025. The largest total came from Foundation Medicine, Inc.
How long has Dr. Alison Semrad been practicing?
Dr. Semrad graduated from medical school in 2004, 22 years ago.
Does Dr. Alison Semrad do research?
Dmand AI links 14 publications to Dr. Semrad, published from 2013 to 2021. Dr. Semrad has worked on 10 clinical trials.
Who does Dr. Alison Semrad publish with?
Dr. Semrad's most frequent co-authors are Thomas J. Semrad, MAS, MD (7 shared papers), Donald Gregory Farwell, MD (3 shared papers) and Michael J. Campbell, MD (2 shared papers).
Selling to endocrinology, diabetes and metabolism practices?
See endocrinologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card